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In the mouse model of pancreas endocrine tumor, loss of Vegf (VKO) results in dramatically decreased
tumor progression; however, the residual microscopic lesions show increased invasion into surrounding
exocrine tissue. Double KO mice of Vegf and hypoxia inducible factor-1a (Hif-1a) showed increased life
span and suppressed tumor growth due to increased apoptosis. The increased invasiveness of tumors in
VKOmicewasdiminishedinDKOmicetothelevelsofwild-typemice.ComparedtoVKOmice,DKOmice
also exhibited smaller changes in the expression levels of adhesion molecules, including E-cadherin,
N-cadherin, and NCAM. These changes of adhesion molecules were not observed in the primary culture of
the tumor cells under hypoxic conditions. Thus, the invasive phenotype observed under angiogenesis
inhibition requires Hif-1a, but is not directly caused by acute hypoxia.
V
EGFpathwayinhibitorsthatimpairtumorangiogenesisandgrowtharecurrentlyinclinicaluse
1.Recently,
we and others have reported that angiogenesis inhibition in murine tumor models leads to promotion of
tumor invasion and metastasis
2,3. The RIP1-Tag2 transgenic mouse model overexpresses SV40 T antigen
under the control of the insulin promoter, resulting in development of islet cell tumors
4. We demonstrated that
VEGF-targeted drugs, as well as gene deletion of Vegf, inhibit primary tumor growth but promote tumor
invasiveness and metastasis in the RIP1-Tag2 model
2. VEGF inhibition generates widely hypoxic regions
1 and
there is a well-documented link between hypoxia and invasive phenotype
5,6, thus, we speculated that hypoxia
contributes to the invasive phenotype in the RIP1-Tag2 model
1.
Hypoxia inducible factor-1a (HIF-1a) is a transcription factor that regulates gene expression under hypoxic
conditions
7. HIF-1a modulates the expression of genes involved in tumorigenesis, such as angiogenesis, meta-
bolism, apoptosis/survival, and invasion/metastasis
7. HIF protein is constitutively synthesized, but degraded
undernormoxicconditionsbytheubiquitin/proteasomesystem;underhypoxicconditionsitisstabilizedbecause
the degradation machinery requires molecular oxygen. Once stabilized, HIF-1a heterodimerizes with HIF-1b to
act as a transcription factor, controlling a wide range of genes involved in the hypoxic response. HIF-regulated
hypoxic responses are involved in cell motility, as well as invasion and metastasis in vivo
8–10. Indeed, clinical
studies have demonstrated a correlation between high HIF expression and poor clinical prognosis
11–14.
The alterations of the microenvironment following angiogenesis inhibition are poorly understood; they likely
include complex changes in oxygen tension, reactive oxygen species, metabolites, and growth factors. Many of
these changes involve HIF-1a
7, thus we speculated that HIF-1a might play an important role in the micro-
environment where angiogenesis is disturbed. Here, using a genetic targeting strategy, we investigated the
contribution of Hif-1a to the changes of tumor phenotype in the Vegf-deleted islet tumors in RIP1-Tag2 mice.
Results
Hif-1a deletion in the RIP1-Tag2/VKO tumors. Conditional deletion of Hif-1a in insulin-secreting cells was
performed using the Cre/lox system
15,16. No remarkable changes were observed in the islet-specific Hif-1a-null
mice (RipCre/Hif-1a
fl/fl) as previously reported
17,18. Hif-1a deletion in the tumors of RIP1-Tag2/RipCre/Hif-1a
fl/fl
(RIP1-Tag2/HKO)micewasconfirmedatthelevelsofgenome,mRNA,andprotein(seeSupplementaryFig.S1).
Next, we generated RIP1-Tag2 mice lacking both Vegf and Hif-1a, RIP1-Tag2/RipCre/Hif-1a
fl/f/Vegf
fl/fl (RIP1-
Tag2/DKO).
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(Fig.1a).ThelifespansoftheRIP1-Tag2/HKOmice(n527,median
12.7 weeks) and RIP1-Tag2/RipCre/Hif-1a
wt/wt (RIP1-Tag2/Cre)
mice (n 5 18, median 13.2 weeks) were almost the same, but were
significantly (p,0.0001) shorter than that of RIP1-Tag2/RipCre(-)
(RIP1-Tag2/wt) mice (n 5 93, median 16.1 weeks). RIP1-Tag2/
RipCre/Vegf
fl/fl (RIP1-Tag2/VKO) mice (n 5 33, median 19.7 weeks)
lived significantly (p,0.0001) longer than the RIP1-Tag2/wt mice.
RIP1-Tag2/DKOmice(n522,median20.6weeks)livedslightlybut
significantly (p,0.05) longer than RIP1-Tag2/VKO mice.
Microscopic analysis revealed that the tumor progression was
equally accelerated in RIP1-Tag2/Cre and RIP1-Tag2/HKO mice,
although the morphology of these tumors at each stage was the same
as that of the RIP1-Tag2/wt tumors (see Supplementary Fig. S2).
These results indicate that forced expression of Cre recombinase in
the insulin-secreting cells accelerated tumor progression in RIP1-
Tag2 mice, and deletion of Hif-1a did not have a remarkable effect
on RIP1-Tag2/Cre tumors.
At 13–15 weeks, the invasive phenotype is remarkably increased
in RIP1-Tag2/VKO mice
4. As most of the RIP1-Tag2/Cre and
RIP1-Tag2/HKO mice died at this time point, we compared RIP1-
Tag2/wt, RIP1-Tag2/VKO, and RIP1-Tag2/DKO at 13–15 weeks for
further analysis of the invasive phenotype.
Tumor growth was suppressed in the RIP1-Tag2/DKO tumors.
Firstly, the tumors were macroscopically examined. The RIP1-Tag2/
wt tumors were red in color with a smooth surface, while the tumors
in RIP1-Tag2/VKO mice were white in color with a rough surface
(Fig. 1b). Tumors greater than 2 mm
3 in volume were rarely
observed in RIP1-Tag2/VKO mice (Fig. 1c). In RIP1-Tag2/DKO
mice, the tumors were whitish, as in RIP1-Tag2/VKO mice, and all
ofthetumorswerelessthan2 mm
3involume.Next,thetumorswere
microscopically examined. Size distribution of microscopic tumors
was about the same between RIP1-Tag2/wt and RIP1-Tag2/VKO
mice (Fig. 1d), in contrast to the drastically decreased number of
larger macroscopic tumors in RIP1-Tag2/VKO (Fig. 1c). These
results indicate that tumors can grow at microscopic levels despite
decreased microvessels
16. Meanwhile, ratio of larger microscopic
lesions in RIP1-Tag2/DKO mice was significantly less than RIP1-
Tag2/VKO mice (Fig. 1d).
Figure 1 | Hif-1a was necessary for growth of RIP1-Tag2/VKO tumors. (a) Kaplan-Meier survival curves of the indicated transgenic mice.
(b) Macroscopic pictures of the isolated tumors. Scale bar, 2 mm. (c) Volume of tumors with maximum diameters . 1 mm. (d) Size distribution
of microscopic tumors. Values are mean and 95-% confidence intervals. *P , 0.05.
www.nature.com/scientificreports
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We investigated the mechanism underlying the reduced number of
larger microscopic lesions in RIP1-Tag2/DKO mice. Microvessel
area was dramatically decreased in the tumors of RIP1-Tag2/VKO
compared with RIP1-Tag2/wt
16, but was about the same in the
tumors of RIP1-Tag2/DKO and RIP1-Tag2/VKO (see Supplementary
Fig. S3), indicating that alterations in angiogenesis are not likely to be
the major cause of growth suppression.
Tumor growth is determined by the balance between cell prolif-
eration and cell death
19. The overall proliferation rate in RIP1-Tag2/
VKO mice was significantly lower than in RIP1-Tag2/wt and RIP1-
Tag2/DKOmice(Fig.2a,b).Next,weevaluatedthedifferencesofcell
Figure 2 | Hif-1a was necessary for survival of cancer cells in RIP1-Tag2/VKO tumors. (a) Immunohistochemistry of the tumors. Red, BrdU; green,
pimonidazole; blue,DAPI. Scale bar, 100mm. (b) Quantification of BrdU uptake in the overall RIP1-Tag2 lesions. Values are mean and 95-% confidence
intervals. (c) Quantification of BrdU incorporation in different locations. Values are mean and 95-% confidence intervals. (d) TUNEL staining of RIP1-
Tag2tumors.Red,Apoptag;green,pimonidazole;blue,DAPI.Scalebar,100mm.(e)QuantificationofcelldeathintheoverallRIP1-Tag2lesions.Values
aremeanand95-%confidenceintervals.(f)Quantificationofcelldeathinlocationsrelativetothepimonidazole-positiveareas,asin(d).Valuesaremean
and 95-% confidence intervals. Statistical analaysis was performed between the pooled areas from different genotypes.
www.nature.com/scientificreports
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patterns(seeSupplementaryFig.S4).TheRIP1-Tag2/wtlesionswere
entirely pimonidazole negative, so all the regions were classified as
distal. In the RIP1-Tag2/VKO lesions, the proliferation rate was
decreased inside the pimonidazole positive area compared with in
the proximal and distal areas (Fig. 2c). In RIP1-Tag2/DKO, the pro-
liferation rate was higher in all lesions than in RIP1-Tag2/VKO
lesions. Thus, Hif-1a may suppress cell proliferation in hypoxic
regions, although this does not explain the decrease of microscop-
ically large lesions in RIP1-Tag2/DKO mice.
Next, we evaluated cell death by TUNEL staining (Fig. 2d). The
overall apoptotic rate in the tumors from RIP1-Tag2/DKO mice was
higherthanfromRIP1-Tag2/wtandRIP1-Tag2/VKOmice(Fig.2e).
When the localized differences in cell death were evaluated, the
apoptotic rate of RIP1-Tag2/DKO was significantly higher in areas
distant from the pimonidazole-positive areas (Fig. 2f). The same
pattern was obtained with cleaved caspase-3 staining, indicating
the death is caspase-3 dependent apoptosis (Supplementary Fig.
S4b).These results indicate that the decrease of microscopic lesions
inRIP1-Tag2/DKO mice wasattributed to celldeathintherelatively
oxygenized regions, and that Hif-1a was necessary for survival of
cancer cells in these regions.
Hif-1a was necessary for invasive phenotype of RIP1-Tag2/VKO
tumors. To evaluate the invasive phenotype, the lesions were
classified according to the previously reported grading system
20
(Fig. 3a). Neither angiogenic islets nor islet tumors were observed
in RIP1-Tag2/VKO and RIP1-Tag2/DKO. An increased number of
invasive lesions was observed in RIP1-Tag2/VKO compared with
RIP1-Tag2/wt (Fig. 3b)
2, while the number of invasive legions
observed in RIP1-Tag2/DKO was similar to that in RIP1-Tag2/wt.
Thus, Hif-1a was necessary for the invasive phenotype in the RIP1-
Tag2/VKO tumors.
Hif-1a was necessary for the change of adhesion molecules of
RIP1-Tag2/VKO tumors. To further investigate the mechanism
underlying the invasive phenotype in RIP1-Tag2/VKO mice, we
examined the expressions of adhesion molecules, including E-
cadherin, N-cadherin, and NCAM. Altered adhesion molecule
expressions are reportedly involved in invasiveness of cancer
cells
21,22 and, moreover, involvement of E-cadherin and NCAM in
the invasion and metastasis in RIP1-Tag2 tumors was previously
demonstrated
23–25. In most of the RIP1-Tag2 tumors, homoge-
nous E-cadherin, N-cadherin, and NCAM staining was observed
with membrane localization
26 (Fig. 3c,d). In contrast, regions of
remarkably low-intensity staining of these adhesion molecules
were frequently observed in RIP1-Tag2/VKO tumors (Fig. 3c,d,e).
Intheseregions,theexpressionsofE-cadherin/N-cadherin aswellas
of E-cadherin/NCAM were reciprocal (Fig. 3c,d). Compared to
RIP1-Tag2/VKO mice, RIP1-Tag2/DKO mice exhibited a sig-
nificantly lower incidence of tumors with impaired E-cadherin
expression, with levels similar to those of RIP1-Tag2/wt mice
(Fig. 3c,d,e). Pimonidazole-positive staining was observed mainly
in the core region of the RIP1-Tag2/VKO tumors, separate from
the invasive front, and the adhesion molecule expressions were not
consistently co-localized with the hypoxic regions (Fig. 3f).
Changes of the adhesion molecules in RIP1-Tag2/VKO tumors
are not due to acute hypoxic response. To investigate whether the
altered expressions of the adhesion molecules were due to the hypoxic
response, we applied a recently developed primary culture technology,
the CTOS (cancer tissue-originated spheroid) method
27.C T O S s
were prepared from RIP1-Tag2/wttumors (Fig.4a, see Supplementary
Fig. S5a). The cells in CTOS shared similar morphology with the
original tumor cells, and the cells stained positive for insulin (Sup-
plementary Fig. S5b). The expression patterns of the genes associated
with RIP1-Tag2 tumor progression, such as increased IGF2
28 and
decreased GLUT2
29, were similar between the CTOSs and the
original tumors (Supplementary Fig. S5c). Thus, CTOS preserved
the characteristics of the original tumors. The cell death in the
CTOSs after 24 h of culture was minimum and equivalent under
normoxic and hypoxic conditions (Supplementary Fig. S5d). When
the CTOSs were cultured in hypoxia for 24 h, Hif-1a protein levels
were dramatically increased (Fig. 4b), as were expressions of Hif-1a
target genes, including Glut1, LdhA, and Pdk1 (Fig. 4c). In contrast,
mRNA levels of E-cadherin and N-cadherin did not change after 24 h
culture under hypoxic conditions (Fig. 4d). NCAM expression was
increased in hypoxia. Whole-mount staining of CTOSs revealed that
the levels and the localization of E-cadherin and N-cadherin did not
change within 24 h (Fig. 4e). These findings, taken together with the
lack of correlation between hypoxic regions and localization of
changed expressions of adhesion molecules in vivo (Fig. 3f), indicate
that the changed expressions of adhesion molecules was not likely to
be an acute hypoxic response. Meanwhile, expressions of twist and
vimentin were increased in the hypoxic CTOSs, suggesting that
epithelial-mescenchymal transition (EMT) might play a role. It is
also possible that exposure to hypoxic conditions for 24 h might
not be enough to observe downregulation of E-cadherin, as the
decrease of E-cadherin expression is often delayed in EMT
30.
Discussion
We showed that Hif-1a is necessary for the invasive phenotype of
RIP1-Tag2/VKO tumors, although the mechanism of Hif-1a activa-
tion is still unclear. We did not find direct evidence that Hif-1a is
induced by hypoxia. Conversely, pimonidazole staining was usually
observed deep inside the tumors, away from the invasive front. As
pimonidazole detects areas of extremely low oxygen tension, Hif-1a
might be activated in the pimonidazole-negative and moderately
hypoxic areas, as previously reported
31. It is also possible that Hif-
1a was activated by other factors than hypoxia. Some of the growth
factorsareknowntoincreasethesynthesisofHif-1aprotein
32.Inthe
RIP1-Tag2/VKO tumors, impaired circulation system might result
in retention of secreted molecules such as growth factors.
Alternatively, Hif-1a might be activated by reactive oxygen species
(ROS).Attheinvasivefront,oxygentensionshouldberelativelyhigh
because tumor cells are close to the normal vessels in adjacent exo-
crine tissue. Oxidative phosphorylation in insulin-secreting cells
33
might generate ROS, which can stabilize Hif-1a protein.
It also remains to be determined what downstream mechanism of
Hif-1a induces the invasive phenotype. Several Hif-1a target genes
arereportedlyinvolvedintheinvasivenessofcancercells
34–36,includ-
ing HGF and c-Met
5. Our results indicate that it is unlikely that a
direct and/or acute Hif-1a response caused the invasive phenotype.
OnecandidatemechanismforachronicorindirecteffectofHif-1ais
EMT
30, particularly since we observed increased expressions of twist
and vimentin in primary cultured tumor cell spheroids. We did not
observe decrease of E-cadherin expression after 24 h culture of the
tumor spheroids under hypoxic conditions. Methods for long time
culture are still under development. As the change of E-cadherin
expression takestimein somecasescompared withthe transcription
factors
30, it remains possible that downregulation of E-cadherin in
vivo is due to EMT. In some situations, a ‘‘cadherin switch’’ occurs,
where downregulation of E-cadherin is accompanied with upregula-
tion of N-cadherin
37. The change in cadherin profile observed in this
study might be due to trans-differentiation from beta-cells to other
type of cells, which might have invasive potential. Alternatively,
invasive clones might be selected by hypoxia, as the invasive tumors
were observed also in RIP1-Tag2/wt tumors at low frequency. More
frequently observed apoptosis in the absence of Hif-1a, could also
suggest that HIF-1a supports the survival of tumor cells in the dete-
riorated microenvironment due to impaired angiogenesis.
Paradoxical expression of HIF-1a and VEGF is reported in
invasive pancreatic endocrine tumors
38. We observed that VEGF
www.nature.com/scientificreports
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mentaryfigureS6).Althoughisletsarehighlyvascularizedorganand
it depends on the expression of VEGF
16, the role of HIF in the
expression of VEGF in pancreas islets might be minimum at the
constitutive levels at least.
Inthisstudy,werevealedthatHif-1awasnecessaryforthegrowth
as well as the induction of invasive phenotype in the RIP1-Tag2/
Vegf-null tumors. Combining the antiangiogenic drugs with an
HIF inhibitor might be helpful to counteract the switch to more
aggressive behavior that is elicited by VEGF inhibition.
Methods
Animal study. The animal experiments were approved by the institutional
committeeofanimalcareoftheOsakaMedicalCenterforCancerandCardiovascular
Diseases. Gene deletion specifically in the insulin-producing cells was achieved with
the Cre/lox system
16. RIP1-Tag2, Hif-1a lox mice
15, RipCre mice, and Vegf lox mice
16
werepreviouslydescribed.Allmousestrainswereback-crossedtoC57Bl/6foratleast
5 generations before making compound transgenic mice.
Cell culture. Cells were cultured in a humidified atmosphere of 5% CO2/95% air at
37uC, unless otherwise noted. Hypoxic conditions were achieved using a hypoxic
workbench(INVIVO2400,RuskinnTechnology,Bridgend,UK)toincubatecellsina
humidified atmosphere of 1% O2 and 5% CO2 at 37uC.
CTOS preparation and culture. Cancer tissue-originated spheroids (CTOSs) were
prepared as previously described
27. Briefly, tumors were dissected from pancreases,
and placed in StemPro hESC SFM Complete medium (Life Technologies) on a non-
coated dish. The tumors were torn with needles and the tumor fragments were
culturedovernightinthemedium.CTOSformationwasconfirmedandthespheroids
were picked up with a pipet under a microscope.
Figure 3 | HIF-1a was necessary for invasive phenotype of RIP1-Tag2/VKO tumors. (a) Microscopic features of the tumors. Representative H&E-stained
tumors in each grade are shown. N, normal shaped lesion; H, hyperplasic; A, angiogenic; IT, insulin tumor; IC, invasive carcinoma. (b) Grading of
microscopiclesionsbytheextentofinvasion.IT,notinvasive;IC1,moderatelyinvasive;IC2,highlyinvasive.Valuesaremeanand95-%confidenceintervals.
*P , 0.05. (c, d) Double staining of E-cadherin and N-cadherin (c) or NCAM (d) in RIP1-Tag2/DKO tumors. Red, E-cadherin (E-cad); green, N-cadherin
(N-cad) or NCAM; blue, Hoechst 33342. T, tumor; Exo, exocrine tissue. The boundary of the tumor and the exocrine pancreas is traced with a dotted line.
Scale bar, 100 mm.(e)FrequencyoftumorswithmixedE-cadherinexpressionamongtheinvasivetumors,shownasthepercentage.Valuesaremeanand95-
% confidence intervals. (f) Immunohistochemistry of a RIP1-Tag2/VKO tumor. Red, E-cad; green, pimonidazole; blue, Hoechst33342. Scale bar, 100 mm.
www.nature.com/scientificreports
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transcribed with SuperScript III (Invitrogen) using the pd(N)6 primer. Real-time
PCRwasperformedusingSYBRPremixExTaq(PerfectRealtime)(RR041A,TaKaRa
BIO, Inc.) and the ABI PRISM 7500 Real-Time PCR System (Applied Biosystems).
The sequences of the primers are provided in the supplementary information.
Western blotting. Cells were collected in ice-cold PBS, and immediately centrifuged
for 5 min at 4uC. The pellets were dissolved in lysis buffer containing the protease
inhibitors aporotinin and leupeptin. The primary antibody was anti-HIF (NB100-
105, 151000, NOVUS BIOLOGICALS) and the horseradish peroxidase-conjugated
secondary antibody was anti-mouse IgG (sc-2005, 152500, Santa Cruz
Biotechnology, Inc.).
Tumor grading. The paraffin-embedded samples were serially sectioned into 5-mm-
thick slices; four sections from 50-mm intervals spanning 200 mm were H&E stained.
At least five mice per genotype were analyzed. Grading of the RIP1-Tag2 tumors was
performed as previously described
20. The well-vascularized lesions were observed,
approximately 10%, both in RIP1-Tag2/VKO and RIP1-Tag2/DKO mice. As we
previously showed
16, the lesions are ‘leaky lesions’, in which Vegf gene is not deleted
due to incompleteness of the Cre/lox system. We removed the leaky lesions from the
analysis in this study.
Immunohistochemical analysis. Mice were injected i.p. with 750 mg/kg BrdU
(Roche)or60 mg/kgHypoxyprobe(NaturalPharmaciaInternationalInc.),forBrdU
and pimonidazole labeling experiments, respectively. After two hours, mice were
sacrificed and pancreases harvested. Pancreases were embedded in OCT and frozen.
The frozen samples were serially sectioned into 10-mm-thick slices, and subjected to
each immunohistochemical analysis. The details are provided in the supplementary
information.
Celldeathandproliferationassay.ThesectionswerestainedwithApopTagorBrdU
withDAPI and pimonidazole.Tumors wereclassified intothree regions according to
the relative location to the pimonidazole-positive area: inside, proximal, and distal
(see Supplementary Fig. S4). Five square-shaped, 100-mm
2 areas were randomly
selected within each region. The ratio of TUNEL-positive or BrdU-positive nuclei to
total nuclei was calculated within each area. Three tumors each from at least three
mice were analyzed.
Statistical analysis. Statistical analysis was performed using GraphPad Prism 4
(GraphPad Software). Thevalues presentedin graphs are meanand 95-%confidence
intervals, or mean 6 SD. The differences between groups were examined for
significance with the Student’s t-test, with P-values , 0.05 considered to be
significant. Overall survival was estimated by Kaplan-Meier methods, and examined
by Logrank test.
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